Serious Fatal and Non-Fatal Non-AIDS D efining Illnesses (non-ADI) in Europe

IRR; incidence rate ratio. All variables are time-updated except *included as a time-updated covariate for non-ADIs and a fixed covariate at baseline for ADIs. Model also adjusted for calendar year of follow-up, CD4 nadir, starting cART, region of Europe, gender, HIV exposure category and ethnic origin. +Defined as <12 g/dl or < 14 g/dl for females and males respectively Factors associated with development of ADI or non-ADI Table 3